SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-023225
Filing Date
2017-04-28
Accepted
2017-04-28 16:17:52
Documents
7
Period of Report
2017-06-21
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v465309_def14a.htm DEF 14A 802197
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC sig_stephenfrom.jpg GRAPHIC 15757
4 GRAPHIC logo_eyegate-pharma.jpg GRAPHIC 57146
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC v465309_proxycard-1.jpg GRAPHIC 1005017
7 GRAPHIC v465309_proxycard-2.jpg GRAPHIC 394334
  Complete submission text file 0001144204-17-023225.txt   2831336
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36672 | Film No.: 17795796
SIC: 2834 Pharmaceutical Preparations